Atlas Trials

Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer

Clinical trial NCT00542191 · TERMINATED

Trial details

NCT number
NCT00542191
Sponsor
Leo W. Jenkins Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-07-01
Primary completion
2016-08-02
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.